Search

everythinglearnresearchcommunity

for

Search:↓

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The conclusion is that dermatologists can improve women's skin health but must overcome cultural and economic barriers to do so.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Several doctors received research grants, new workshops and conferences were announced, and new officers were elected.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

A rare ovarian tumor caused high testosterone in a postmenopausal woman, resolved by surgery.

Rare ovarian tumors can cause hyperandrogenism, even if imaging appears normal.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Minoxidil with Korean red ginseng improves hair density and thickness more than minoxidil alone.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.